NCT04453917
- Conditions
- Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
- Locations
-
- CHU Bordeaux Bordeaux, France
- CHU Montpellier Montpellier, France
- CHU de TOULOUSE Toulouse, France
Clinical trial condition
DNA Virus Infections
Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.
3,911 public trials
503 recruiting studies
DNA Virus Infections trial results
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Edegem, Belgium
- GSK Investigational Site Sliven, Bulgaria
- GSK Investigational Site Sofia, Bulgaria
- GSK Investigational Site Sofia, Bulgaria
NCT06901362
- Conditions
- Blood-Borne Infections, Chickenpox, Communicable Diseases, +13 more
- Locations
-
- Narongkorn Saiphoklang Pathum Thani, Changwat Pathum Thani, Thailand
NCT05127187
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
- Locations
-
- CHU Nîmes Nîmes, France
NCT04210336
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
- Locations
-
- Hospital Universitario Nuestra Señora de la Candelaria Santa Cruz de Tenerife, Tenerife, Spain
NCT03077451
- Conditions
- DNA Virus Infections, Herpesviridae Infections, Infections, +9 more
- Locations
-
- University of Miami Miami, Florida, United States
- Emory University/Grady Hospital Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT04690933
- Conditions
- Antiviral Drug Resistance, Antivirals, Cytomegalovirus Infections, +5 more
- Locations
-
- CHU de LIMOGES Limoges, France
- CHU Amiens, France
- CHU Angers, France
- CHU Besançon, France
- Conditions
- DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
Completed
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT04157985
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Anal Cancer, +69 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States